Canopy Growth Corp (CGC)
$24.58
0.46 (1.89%)
CGC Stock Quote Delayed 15 Minutes
Previous Close
$24.12
Market Cap
5.31B
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
3.56M
Day's Range
23.74 - 25.00
52-Week Range
13.81 - 52.74
Dividend & Yield
N/A (N/A)
CGC Stock Predictions, Articles, and Canopy Growth Corp News
Did Canopy Growth Stock Just Have a Dead Cat Bounce?
Canopy’s ramped up spending to get its Cannabis 2.0 products into the hands of consumers, along with launching its first hemp-derived CBD product in the U.S., are two things InvestorPlace’s Mark Hake believes will continue to hurt the company’s margins.
Why Canopy Growth Stock Will Stage a Huge Rebound in 2020
Calendar 2019 was the year that CGC stock lost its "mojo", and 2020 will be the year that the stock gets it back.
Thursday’s Vital Data: Bristol-Myers Squibb, Cronos and Canopy Growth
Options trading was hot in Bristol-Myers Squibb, Cronos and Canopy Growth stock on Tuesday. Here’s what the data suggests moving forward.
Is Canopy Growth a Worthy Investment in 2020?
Canopy Growth has been hammered in 2019, along with the the rest of the cannabis space. Is a rebound ready to go?
It’s Getting Hard to See a Road to Profitability for CGC Stock
Canopy Growth stock outlook darkens with more losses. Canopy Growth reported lower revenue and further losses for its September quarter with profitability nowhere on the horizon.
Can Canopy Growth Rise Above the Cannabis Industry’s Reputation?
The cannabis industry suffered horribly in 2019 and Aurora Cannabis’ controversial executive departure creates a trust issue for Canopy Growth and other major players.
U.S. Cannabis Stocks Will Make Cheap, Smart Buys in 2020
Matt McCall predicts that 2020 will be a better year for U.S. cannabis stocks. He's also calling for a big rally in bitcoin.
Canopy Growth Could Surprise in 2020, but Don’t Rush In
With strong capitalization, Canopy Growth is a "safer" pot stock play. But to tilt the odds in your favor, take your time before buying.
Why Aphria Stock Is Suffering From the Cannabis 2.0 Letdown
Despite the fact that APHA has posted two straight profitable quarters, Aphria stock has been hit hard this week as Cannabis 2.0 stumbles.
Why Canopy Growth Stock is a Buy Today as Cannabis’ Bad Year Nears End
It’s unlikely to be the next Netflix or Microsoft, but Canopy Growth stock has made the case for today’s investors to take a nibble
Pair-Trading Cannabis Stocks: Go Long THC and Short CBD
Cannabis stocks have taken a huge hit in 2019 and will likely remain volatile while the industry goes through its growing pains. Long-term cannabis bulls can consider mitigating their portfolio risk by going long top legal cannabis producers and short CBD-focused stocks.
Can Canopy Growth Stock Double in 2020?
Canopy Growth stock is trying to stage a comeback, but had a difficult 2019. Will 2020 be the year for CGC stock or is false hope building?
Canopy Growth Is Halfway to a Full Blown Recovery
Investors who are looking for marijuana stocks should have CGC on their radar as it looks like the best of the bunch right now.
Can Canopy Growth’s Incoming Chief Executive David Klein Turn a Profit?
Even with its recent run-up, Canopy Growth stock is still down more than 20% for the year. Can Klein turn things around?
After Cratering in 2019, 2020 Will Be a Better Year for CGC Stock
There's no question 2019 has been a brutal year for CGC stock investors. However, nothing has changed about Canopy's long-term bullish thesis, and there are several potential catalysts ahead in 2020.
Canopy Growth Stock Rally Should Offer Many Trading Opportunities
There are profits in trading Canopy Growth stock as the sector finds its footing on Wall Street. CGC is in a rebound effort from earnings.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
D
